LifeVantage (LFVN) announced the results of a third-party cell study on the synergistic impact of Protandim Nrf2 Synergizer ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate ...

Corporation (NASDAQ:LFVN), a company specializing in nutrigenomics, announced the appointment of Todd Thompson as its new Chief Information and Innovation Officer. The company, which has demonstrated ...

LifeVantage Corporation (Nasdaq: LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of ...

Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target Discover ...

LifeVantage (NASDAQ:LFVN) soared in Wednesday trading after the company updated guidance earlier in the day. For FQ2, LifeVantage (NASDAQ:LFVN) sees revenue of $67.5 million vs. $51.5 million ...

In the last week, the United States market has been flat, yet it has seen a 23% increase over the past year with earnings forecasted to grow by 15% annually. In such a dynamic environment, identifying ...

LifeVantage shares soared Wednesday after the company said its financial outlook for 2025 is brighter than previously expected. The health and nutrition company's stock rose 30% to $21.40 in morning ...

SALT LAKE CITY, Dec. 03, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the ...

Corporation announces the addition of Todd Thompson as Chief Information and Innovation Officer. Todd brings decades of ...